276 related articles for article (PubMed ID: 24925443)
1. Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies.
Connelly KA; Advani A; Advani SL; Zhang Y; Kim YM; Shen V; Thai K; Kelly DJ; Gilbert RE
Acta Diabetol; 2014 Oct; 51(5):771-82. PubMed ID: 24925443
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity.
Yoshioka J; Schulze PC; Cupesi M; Sylvan JD; MacGillivray C; Gannon J; Huang H; Lee RT
Circulation; 2004 Jun; 109(21):2581-6. PubMed ID: 15123525
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated Txnip-ROS-Wnt axis contributes to the impaired ischemic heart repair in diabetic mice.
Shen M; Bai D; Liu B; Lu X; Hou R; Zeng C; Li N; Fu Z; Li C; Tao L; Wang H; Yin T
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3735-3745. PubMed ID: 30261287
[TBL] [Abstract][Full Text] [Related]
4. High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.
Qi W; Chen X; Gilbert RE; Zhang Y; Waltham M; Schache M; Kelly DJ; Pollock CA
Am J Pathol; 2007 Sep; 171(3):744-54. PubMed ID: 17675577
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
6. Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.
Myers RB; Fomovsky GM; Lee S; Tan M; Wang BF; Patwari P; Yoshioka J
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1748-59. PubMed ID: 27037370
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.
Schulze PC; Yoshioka J; Takahashi T; He Z; King GL; Lee RT
J Biol Chem; 2004 Jul; 279(29):30369-74. PubMed ID: 15128745
[TBL] [Abstract][Full Text] [Related]
8. HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.
Otaki Y; Takahashi H; Watanabe T; Funayama A; Netsu S; Honda Y; Narumi T; Kadowaki S; Hasegawa H; Honda S; Arimoto T; Shishido T; Miyamoto T; Kamata H; Nakajima O; Kubota I
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796253
[TBL] [Abstract][Full Text] [Related]
9. Diabetes impairs exercise training-associated thioredoxin response and glutathione status in rat brain.
Lappalainen Z; Lappalainen J; Oksala NK; Laaksonen DE; Khanna S; Sen CK; Atalay M
J Appl Physiol (1985); 2009 Feb; 106(2):461-7. PubMed ID: 19074570
[TBL] [Abstract][Full Text] [Related]
10. p38 MAPK pathway is involved in high glucose-induced thioredoxin interacting protein induction in mouse mesangial cells.
Ren Y; Shi Y; Wang Y; Li Y; Wu S; Li H; Zhang Y; Duan H
FEBS Lett; 2010 Aug; 584(15):3480-5. PubMed ID: 20624390
[TBL] [Abstract][Full Text] [Related]
11. Possible role for the thioredoxin system in the protective effects of probucol in the pancreatic islets of diabetic rats.
Liu JH; Liu DF; Wang NN; Lin HL; Mei X
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):528-33. PubMed ID: 21615774
[TBL] [Abstract][Full Text] [Related]
12. Cardiomyocyte-specific Txnip C247S mutation improves left ventricular functional reserve in streptozotocin-induced diabetic mice.
Mukai N; Nakayama Y; Abdali SA; Yoshioka J
Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H259-H274. PubMed ID: 34085839
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer.
Li W; Wu Z; Ma Q; Liu J; Xu Q; Han L; Duan W; Lv Y; Wang F; Reindl KM; Wu E
Curr Cancer Drug Targets; 2014; 14(4):348-56. PubMed ID: 24720336
[TBL] [Abstract][Full Text] [Related]
14. Redox regulation by nuclear factor erythroid 2-related factor 2: gatekeeping for the basal and diabetes-induced expression of thioredoxin-interacting protein.
He X; Ma Q
Mol Pharmacol; 2012 Nov; 82(5):887-97. PubMed ID: 22869588
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity.
Schulze PC; Liu H; Choe E; Yoshioka J; Shalev A; Bloch KD; Lee RT
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2666-72. PubMed ID: 17023680
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia-induced thioredoxin-interacting protein expression differs in breast cancer-derived cells and regulates paclitaxel IC50.
Turturro F; Von Burton G; Friday E
Clin Cancer Res; 2007 Jun; 13(12):3724-30. PubMed ID: 17575238
[TBL] [Abstract][Full Text] [Related]
17. Expression, localization, and function of the thioredoxin system in diabetic nephropathy.
Advani A; Gilbert RE; Thai K; Gow RM; Langham RG; Cox AJ; Connelly KA; Zhang Y; Herzenberg AM; Christensen PK; Pollock CA; Qi W; Tan SM; Parving HH; Kelly DJ
J Am Soc Nephrol; 2009 Apr; 20(4):730-41. PubMed ID: 19211714
[TBL] [Abstract][Full Text] [Related]
18. Txnip C247S mutation protects the heart against acute myocardial infarction.
Nakayama Y; Mukai N; Wang BF; Yang K; Patwari P; Kitsis RN; Yoshioka J
J Mol Cell Cardiol; 2021 Jun; 155():36-49. PubMed ID: 33652022
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231.
Turturro F; Friday E; Welbourne T
BMC Cancer; 2007 Jun; 7():96. PubMed ID: 17555594
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes.
Chong CR; Chan WP; Nguyen TH; Liu S; Procter NE; Ngo DT; Sverdlov AL; Chirkov YY; Horowitz JD
Cardiovasc Drugs Ther; 2014 Aug; 28(4):347-60. PubMed ID: 25088927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
